NR4A1 and breast carcinoma: These figures are strikingly similar to those obtained by Cheang and colleagues [21] using a rabbit monoclonal antibody to Ki-67 (clone SP6) in a series of 2847 hormone receptor-positive breast carcinomas, and showing a 59% prevalence of Luminal A-like tumors.